Ken Somberg's Bio

Ken has senior leadership experience in global pharma and contract research organizations with demonstrated expertise in corporate strategy, clinical research design, clinical trial operations, regulatory affairs, business development, due diligence and global team management. Known for bringing medical/scientific perspective to corporate strategy development, he most recently served as Chief Medical Officer of Covance Inc., a leading global contract research organization (CRO). Prior experience at Novartis Pharmaceuticals as a global therapeutic area head in both Clinical Research (Transplantation and Immunology) and Regulatory Affairs (infectious Diseases, Transplantation and Immunology) included the development and approval of drugs across a variety of indications. He also led engagement with numerous global health authorities including FDA, EMA, PMDA as well as a number of European national authorities. At both Covance and Novartis responsibilities included due diligence and assessment of licensing and acquisition opportunities. Prior to joining industry Ken served on the faculty at the University of California, San Francisco as Associate Medical Director of the Liver Transplantation Program.

During his time at Novartis, Ken worked across a variety of indications including multiple sclerosis, rheumatoid arthritis, Crohn’s disease, psoriasis, solid-organ transplantation, hepatitis B and C, Muckle-Wells syndrome, bacterial infections, and sepsis amongst others. While at Covance he oversaw drug development planning and execution across the therapeutic spectrum including Cardiovascular disease, Diabetes Mellitus, Oncology, Neuroscience, Rare and Orphan diseases, Infectious Diseases, Inflammation and General Medicine.